These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4654667)

  • 41. [Effect of steroids with anti-androgenic properties on the androgenic and myotrophic activity of testosterone and its various derivatives].
    Ivanenko TI
    Probl Endokrinol (Mosk); 1978; 24(4):86-91. PubMed ID: 683979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of a brain-enhanced estradiol delivery system on testosterone and androgen-dependent tissues. II. The role of testosterone.
    Anderson WR; Rahimy MH; Brewster ME; Bodor N; Simpkins JW
    Endocrinology; 1991 Aug; 129(2):726-33. PubMed ID: 1855470
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new class of long-acting hormonal steroid preparation: synthesis of dimeric androgenes coupled at C3-C3 and C17-C3 and of an androgen-progestogen combination.
    Kuhl H; Taubert HD
    Steroids; 1976 Jul; 28(1):89-99. PubMed ID: 960149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Augmentation of the effects of testosterone propionate by cortisol in immature male rats.
    Klaiber EL; Lloyd C; Solomon A; Broverman DM
    Endocrinology; 1968 Aug; 83(2):387-9. PubMed ID: 5663496
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of estradiol-17-beta on the seminal vesicle and ventral prostate of immature castrate rats.
    Fujii T; Villee CA
    Endocrinology; 1968 Nov; 83(5):1140-5. PubMed ID: 5685574
    [No Abstract]   [Full Text] [Related]  

  • 46. The effects of 5alpha-reduced androgens on maintenance and regeneration of prostate glands and seminal vesicles in castrated and hypophysectomized rats.
    Ahmad N; Warren DW; Haltmeyer GC
    Anat Rec; 1978 Dec; 192(4):543-54. PubMed ID: 736274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimal testosterone concentration for the treatment of prostatic cancer.
    Trachtenberg J
    J Urol; 1985 May; 133(5):888-90. PubMed ID: 3989932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hershberger assay to investigate the effects of endocrine-disrupting compounds with androgenic or antiandrogenic activity in castrate-immature male rats.
    Gray LE; Furr J; Ostby JS
    Curr Protoc Toxicol; 2005 Dec; Chapter 16():Unit16.9. PubMed ID: 20963763
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of new multi-site hormone blockers on the fertility of male rats.
    Goldman AS; Shapiro BH; Root AW
    J Endocrinol; 1976 Apr; 69(1):11-21. PubMed ID: 1270948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mifentidine: evaluation of antiandrogen effects and kidney function studies.
    Francalanza G; Franco C; Giachetti A
    Arzneimittelforschung; 1985; 35(1A):456-8. PubMed ID: 2859037
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Synthesis and antiandrogenic activity of 17-deoxysteroids].
    Masuoka Y; Masuoka M; Goto G; Hiraga K; Nakayama R; Miki T; Sumi M
    Yakugaku Zasshi; 1983 Oct; 103(10):1046-53. PubMed ID: 6674485
    [No Abstract]   [Full Text] [Related]  

  • 52. Development of androgen-independent carcinomas from androgen-dependent preneoplastic lesions in the male accessory sex organs of rats treated with 3,2'-dimethyl-4-aminobiphenyl and testosterone propionate.
    Iwasaki S; Kato K; Mori T; Takahashi S; Futakuchi M; Shirai T
    Jpn J Cancer Res; 1999 Jan; 90(1):23-30. PubMed ID: 10076561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hershberger assay for antiandrogenic effects of phthalates.
    Lee BM; Koo HJ
    J Toxicol Environ Health A; 2007 Aug; 70(15-16):1365-70. PubMed ID: 17654256
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-androgen TSAA-291. I. Anti-androgenic effects of a new steroid TSAA-291 (16 beta-ethyl-17 beta-hydroxy-4-oestren-3-one) and its derivatives.
    Nakayama R; Masuoka M; Masaki T; Shimamoto K
    Acta Endocrinol Suppl (Copenh); 1979; 229():2-23. PubMed ID: 93380
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of antiandrogens on sexual behaviour and gonadal function in male rats.
    Dörner G; Götz F; Mainz K
    Endocrinol Exp; 1972; 6(1):17-27. PubMed ID: 4111333
    [No Abstract]   [Full Text] [Related]  

  • 56. Differences in the mechanism of action of medrogestone and cyproterone acetate.
    Sufrin G; Coffey DS
    Invest Urol; 1975 Jul; 13(1):1-9. PubMed ID: 1140913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on responsiveness of the male rat reproductive system to testosterone stimulation in adulthood.
    Bjerke DL; Sommer RJ; Moore RW; Peterson RE
    Toxicol Appl Pharmacol; 1994 Aug; 127(2):250-7. PubMed ID: 8048068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of castration on the smooth muscle cells of the internal sex organs of the rat: influence of the smooth muscle on the sympathetic neurons innervating the vas deferens, seminal vesicle and coagulating gland.
    Wakade AR; Garcia AG; Kirpekar SM
    J Pharmacol Exp Ther; 1975 May; 193(2):424-34. PubMed ID: 1142099
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis of an androgenic-anabolic nonsteroid.
    Zanati G; Wolff ME
    J Med Chem; 1973 Jan; 16(1):90-1. PubMed ID: 4118299
    [No Abstract]   [Full Text] [Related]  

  • 60. Prolactin influences upon androgen action in male accessory sex organs.
    Thomas JA; Keenan EJ
    Adv Sex Horm Res; 1976; 2():425-70. PubMed ID: 189591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.